TD Asset Management’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-267,656
Closed -$840K 1269
2024
Q4
$840K Buy
267,656
+93,276
+53% +$452K ﹤0.01% 1131
2024
Q3
$860K Buy
+174,380
New +$900K ﹤0.01% 1218
2023
Q4
Sell
-75,164
Closed -$764K 1440
2023
Q3
$764K Buy
75,164
+13,554
+22% +$288K ﹤0.01% 1193
2023
Q2
$1.29M Buy
+61,610
New +$1.26M ﹤0.01% 1075

Other funds holding SLRN

TD Asset Management's SLRN Position: Q1 2025 in Review

TD Asset Management sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 267,656 shares — an estimated $840K sold.

TD Asset Management first reported a position in SLRN in Q2 2023 and held it in 4 quarters. The position peaked at $1.29M in Q2 2023. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.

  • TD Asset Management reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
  • TD Asset Management sold 267,656 ACELYRIN shares in Q1 2025, an estimated $840K.
  • TD Asset Management first reported a position in ACELYRIN in Q2 2023 and held it in 4 quarters.
  • TD Asset Management's ACELYRIN position peaked at $1.29M in Q2 2023.
  • 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.

Based on TD Asset Management's 13F filing for Q1 2025, filed 7 May 2025.